Literature DB >> 21073257

Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.

Kentaro Mori1, Takuji Yamamoto, Masahiro Miyazaki, Yasukazu Hara, Yasuhisa Aiko, Nobuhiro Koike, Shinsuke Sakamoto, Yasuaki Nakao, Takanori Esaki.   

Abstract

OBJECT: The optimal CSF Mg(++) concentration for vasodilation of spastic cerebral arteries after subarachnoid hemorrhage (SAH) and its duration are unknown. The temporal profile of the vasodilatory effect and optimal CSF Mg(++) concentration after the intracisternal injection of MgSO(4) solution were investigated in an SAH model in canines.
METHODS: Cerebral vasospasm was induced by experimental SAH using a 2-hemorrhage model in 26 female beagles. On Day 7, 0.5 ml/kg of 15, 10, 5, or 0 mmol/L MgSO(4) in Ringer solution was injected into the cerebellomedullary cistern. Angiography was performed on Day 1 (before SAH) and before and 1, 3, and 6 hours after the intracisternal injection on Day 7 to measure arterial diameters of the basilar artery (BA), superior cerebellar artery (SCA), and vertebral artery (VA). Cerebrospinal fluid Mg(++) was also measured at the same time.
RESULTS: Arterial diameters of the BA, SCA, and VA were significantly decreased by vasospasm on Day 7. Arterial diameter ratios (ratio of arterial diameter after MgSO(4) injection to diameter before injection on Day 7) of the BA and SCA at 1 and 3 hours after and the VA at 1 hour after intracisternal injection of the MgSO(4) solution were positively correlated with the CSF Mg(++) concentration. All arterial diameter ratios, except 1 point of the SCA, exceeded 1 if the CSF Mg(++) concentration was > 3 mEq/L at 1 hour after injection. Animals with CSF Mg(++) concentrations > 3 mEq/L at 1 hour after injection (11 dogs) showed significantly increased arterial diameters of the BA at 1 and 3 hours after and of the SCA and VA at 1, 3, and 6 hours after injection, as compared with the diameters before injection. The CSF Mg(++) concentration significantly increased at 1 hour (3.73 ± 0.69 mEq/L, p < 0.01) and 3 hours (2.05 ± 0.35 mEq/L, p < 0.01) after the intracisternal injection as compared with the baseline value (1.41 ± 0.20 mEq/L).
CONCLUSIONS: The reversible effect of an intracisternal injection of MgSO(4) solution on the spastic artery requires CSF Mg(++) concentrations > 3 mEq/L. The vasodilatory effect continues for 3-6 hours after injection. These results suggest that the continuous infusion or intermittent intracisternal injection of MgSO(4) is needed to maintain the optimal CSF Mg(++) concentration and constantly ameliorate cerebral vasospasm.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073257     DOI: 10.3171/2010.10.JNS10866

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

Review 1.  Double cisterna magna blood injection model of experimental subarachnoid hemorrhage in dogs.

Authors:  Kentaro Mori
Journal:  Transl Stroke Res       Date:  2014-07-03       Impact factor: 6.829

2.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

3.  The role of magnesium in the management of cerebral vasospasm.

Authors:  Mitchell J Odom; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-05-21

4.  Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jin Sue Jeon; Seung Hun Sheen; Gyojun Hwang; Suk Hyung Kang; Dong Hwa Heo; Yong-Jun Cho
Journal:  J Korean Neurosurg Soc       Date:  2012-08-31

5.  Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice.

Authors:  Kentaro Mori; Takuji Yamamoto; Masahiro Miyazaki; Yasukazu Hara; Nobuhiro Koike; Yasuaki Nakao
Journal:  Neurol Med Chir (Tokyo)       Date:  2013       Impact factor: 1.742

6.  Magnesium lithospermate B, an active extract of Salvia miltiorrhiza, mediates sGC/cGMP/PKG translocation in experimental vasospasm.

Authors:  Chih-Zen Chang; Shu-Chuan Wu; Aij-Lie Kwan
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

7.  Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

Authors:  Satoru Takeuchi; Kentaro Mori; Hirohiko Arimoto; Kazuya Fujii; Kimihiro Nagatani; Satoshi Tomura; Naoki Otani; Hideo Osada; Kojiro Wada
Journal:  BMC Neurol       Date:  2014-09-09       Impact factor: 2.474

8.  Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model.

Authors:  Chih-Zen Chang; Shu-Chuan Wu; Chia-Mao Chang; Chih-Lung Lin; Aij-Lie Kwan
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.